Ameriprise’s Enfusion, Inc. ENFN Stock Holding History

Ameriprise’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,263	Closed	-$672K	–	4167
2025 Q1	$672K	Buy	+60,263	New	+$666K	﹤0.01%	3381
2022 Q1	–	Sell	-906,319	Closed	-$19M	–	4037
2021 Q4	$19M	Buy	+906,319	New	+$18.3M	0.01%	1456

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameriprise's ENFN Position: Q2 2025 in Review

Ameriprise sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 60,263 shares — an estimated $672K sold.

Ameriprise first reported a position in ENFN in Q4 2021 and held it in 2 quarters. The position peaked at $19M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Ameriprise reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Ameriprise sold 60,263 Enfusion, Inc. shares in Q2 2025, an estimated $672K.
Ameriprise first reported a position in Enfusion, Inc. in Q4 2021 and held it in 2 quarters.
Ameriprise's Enfusion, Inc. position peaked at $19M in Q4 2021.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.